Oragenics (OGEN) Competitors $0.19 +0.00 (+1.20%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$0.19 0.00 (-0.15%) As of 08:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock OGEN vs. UPXI, MBRX, NRSN, INAB, FLGC, BCDA, GOVX, EQ, EDSA, and LPTXShould you be buying Oragenics stock or one of its competitors? The main competitors of Oragenics include Upexi (UPXI), Moleculin Biotech (MBRX), NeuroSense Therapeutics (NRSN), IN8bio (INAB), Flora Growth (FLGC), BioCardia (BCDA), GeoVax Labs (GOVX), Equillium (EQ), Edesa Biotech (EDSA), and Leap Therapeutics (LPTX). These companies are all part of the "pharmaceutical products" industry. Oragenics vs. Upexi Moleculin Biotech NeuroSense Therapeutics IN8bio Flora Growth BioCardia GeoVax Labs Equillium Edesa Biotech Leap Therapeutics Oragenics (NYSE:OGEN) and Upexi (NASDAQ:UPXI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, community ranking, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment. Which has preferable valuation and earnings, OGEN or UPXI? Oragenics has higher earnings, but lower revenue than Upexi. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOragenics$40K104.31-$20.66M-$1.12-0.17Upexi$16.56M1.17-$23.66MN/AN/A Does the MarketBeat Community prefer OGEN or UPXI? Upexi received 3 more outperform votes than Oragenics when rated by MarketBeat users. Likewise, 42.86% of users gave Upexi an outperform vote while only 0.00% of users gave Oragenics an outperform vote. CompanyUnderperformOutperformOragenicsOutperform VotesNo VotesUnderperform Votes55100.00% UpexiOutperform Votes342.86% Underperform Votes457.14% Do insiders and institutionals have more ownership in OGEN or UPXI? 18.7% of Oragenics shares are owned by institutional investors. Comparatively, 5.7% of Upexi shares are owned by institutional investors. 4.9% of Oragenics shares are owned by company insiders. Comparatively, 31.6% of Upexi shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, OGEN or UPXI? Oragenics has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, Upexi has a beta of -0.27, indicating that its share price is 127% less volatile than the S&P 500. Is OGEN or UPXI more profitable? Upexi's return on equity of 0.00% beat Oragenics' return on equity.Company Net Margins Return on Equity Return on Assets OragenicsN/A -2,087.95% -486.56% Upexi N/A N/A N/A Does the media refer more to OGEN or UPXI? In the previous week, Oragenics and Oragenics both had 2 articles in the media. Upexi's average media sentiment score of 0.34 beat Oragenics' score of 0.23 indicating that Upexi is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oragenics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Upexi 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryUpexi beats Oragenics on 7 of the 11 factors compared between the two stocks. Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGEN vs. The Competition Export to ExcelMetricOragenicsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$4.17M$6.47B$5.33B$19.29BDividend YieldN/A2.64%5.21%3.83%P/E Ratio-0.039.0626.7734.52Price / Sales104.31259.83393.2734.82Price / CashN/A65.8538.2517.51Price / Book0.326.456.774.69Net Income-$20.66M$143.98M$3.23B$1.02B7 Day Performance-2.85%0.38%0.43%-2.43%1 Month Performance0.15%2.14%9.07%6.27%1 Year Performance-91.09%-0.33%18.57%5.78% Oragenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGENOragenicsN/A$0.19+1.2%N/A-92.3%$4.17M$40,000.00-0.035UPXIUpexi0.7259 of 5 stars$10.64+7.4%N/A+45.1%$15.17M$18.63M0.00130News CoverageEarnings ReportHigh Trading VolumeMBRXMoleculin Biotech1.9601 of 5 stars$1.08+2.9%$6.00+455.6%-81.1%$15.12MN/A0.0020NRSNNeuroSense Therapeutics2.6877 of 5 stars$1.10+5.4%N/A+17.7%$15.03MN/A-1.7210Gap UpINABIN8bio2.9795 of 5 stars$0.16+3.6%$6.00+3,581.0%-87.4%$14.80MN/A-0.2220Gap UpFLGCFlora Growth2.4761 of 5 stars$0.75+10.5%$5.00+566.7%-45.6%$14.58M$59.51M-0.57280BCDABioCardia2.7742 of 5 stars$2.84-0.4%$25.00+780.3%-59.0%$14.47M$58,000.00-0.6840Gap UpGOVXGeoVax Labs2.7841 of 5 stars$0.93-0.3%$11.10+1,099.9%-45.5%$14.06M$5.59M-0.2510Positive NewsEQEquillium2.6089 of 5 stars$0.39-0.1%$3.00+669.2%-72.3%$13.93M$41.10M-2.7940EDSAEdesa Biotech2.6178 of 5 stars$1.98-3.4%$21.00+960.6%-56.0%$13.91MN/A-1.0620Analyst RevisionLPTXLeap Therapeutics2.4159 of 5 stars$0.38+12.0%$4.92+1,210.8%-85.2%$13.88MN/A-0.1940Positive NewsGap Up Related Companies and Tools Related Companies Upexi Competitors Moleculin Biotech Competitors NeuroSense Therapeutics Competitors IN8bio Competitors Flora Growth Competitors BioCardia Competitors GeoVax Labs Competitors Equillium Competitors Edesa Biotech Competitors Leap Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OGEN) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OGEN Stock Free OGEN Stock Alerts